Cher Hwa is currently the Senior Vice President (Health Innovation Delivery) for MiRXES.
Previously, he was the Director of the National Health Innovation Centre Singapore (NHIC), an entity under the Consortium for Clinical Research and Innovation Singapore (CRIS) of MOH Holdings. NHIC aims to provide the public clinical research sector of Singapore with funding and guidance to support the translation of an innovation by validating, de-risking or developing it towards a market-ready product. Cher Hwa is the founding member of NHIC and leads a team of innovators promoting the collaboration of researchers, clinicians and industry to better position Singapore to tackle the healthcare challenges of tomorrow.
Prior to joining NHIC, Cher Hwa was at A*STAR’s A*celerate for 7 years as a Vice President in commercialising technologies for the telecommunications and medical technologies sectors. Cher Hwa had also worked at multinational companies in various capacities on product management, sales & marketing, systems integration, and business development for mission critical and telecommunication systems.
Cher Hwa holds a Bachelor of Engineering (First Class Honours) in Electronic Engineering from the University of Sheffield and a Master in Business Administration (MBA) from the University of Manchester.